Evaluation of the Long-term Safety and Tolerability of Metoprolol Versus Nebivolol in Patients With Hypertension
Completed · Phase 3
Conditions studied: Hypertension
In brief
The purpose of this study is to evaluate long-term safety,tolerability and blood pressure effects of metoprolol versus nebivolol in patients with hypertension. These drugs may be given alone or in combination with other drugs that are commonly used in the treatment of hypertension
Key facts
- Study ID
- NCT00142584
- Run by
- Mylan Bertek Pharmaceuticals
- People needed
- 336
- Starts
- 2005-08-01
- Expected to finish
- 2008-03-01
- Last updated by the study team
- 2022-03-15
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Completion of previous nebivolol study
- Stage 1-2 Hypertension (HTN) at baseline of first study
You may not qualify if…
- Recent myocardial infarction or stroke
- Contraindications to beta blocker therapy
Where it is running
- Mylan Pharmaceuticals Inc. — Morgantown, West Virginia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.